• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    Zur Herstellung eines a-Galactosidase produzierenden Mikroorganismus spaltet man sowohl eine ein a-Galactosidase-Gen enthaltende DNA als auch einen für die zu verwendenden trantsformierbaren Zellen geeigneten Vektor, der Antibiotikaresistenzgene enthält, mit Restriktionsendonuclease Sal I vollständig gewinnt aus den Fragmenten der das a-Galactosidase-Gen enthaltende DNA das Bruchstück mit etwa vier Megadalton relativen Molekulargewichts, mischt es mit der Lösung des ebenfalls mit Sal I gespaltenen Vektors und rekombiniert in Gegenwart von DNA-Ligase unter Bildung einer rekombinanten DNA. Die erhaltene rekombinante DNA inkubiert man mit transformierbaren Zellen unter Transformation der rekombinanten DNA in die Zellen, bebrütet die transformierten Zellen auf einem Raffinose als einzige C-Quelle enthaltenden Nährboden, isoliert und lysiert die gebildeten antibiotikaresistenten Kolonien, isoliert aus dem Lysat die Plasmid-DNA, spaltet diese mit Restriktionsendonuclease Hind III oder Eco R I, verdünnt die erhaltene Lösung und behandelt sie mit DNA-Ligase. Die erhaltenen renaturierten Plasmide werden erneut in transformierbare Zellen eingeschleust, die transformier- ten Zellen werden wieder auf einem Raffinose als C-Quelle sowie Antibioticum enthaltenden Nährboden be- brütet und die gebildeten, Raffinose nicht verwertenden Kolonien werden isoliert. Man erhält so einen Mikroorganismus, welcher zwar eine α-Galactosidase, die Cofaktoren nicht benötigt, aber keine Invertase bildet.
    公开号:SU1431681A3
    申请号:SU823448724
    申请日:1982-06-04
    公开日:1988-10-15
    发明作者:Маттес Ральф；Бокамп Клаус
    申请人:Берингер Маннхайм,Гмбх (Фирма)；
    IPC主号:
    专利说明:

     s
    The invention relates to biotechnology and relates to the production of α-galactosidase by genetic engineering.
    The aim of the invention is to increase the purity of the enzyme.
    The production of ct-galactosidase free of invertase activity is obtained by cloning a DNA fragment encoding oi-galactosidase. in the vector rVE 322, with the subsequent selection of the desired clones of the nutrient medium containing raffinose, and the cultivation of bacterial strains - the producers of the final product.
    Example I.-From the Esche- richia coli strain BMTV 2743, DSM 2092, carrying the DNA, containing the oi-galactosidase gene, a new strain is obtained with a higher productivity with respect to o, -galactosidase.
    The Esclieric.hia coli strain BMTV 2743, Itnr, leu, thi, lac Y, tou A, raf, pets-lysogen), obtained from E.coli K-12, BMTV 2744, DSM 2093, is cultured for 4 hours at 30 ° C and shaking in a liter of nutrient medium1 containing 1% tryptone, 0.5%, ;; yeast extract, 0.2% glucose and 0.5% sodium chloride, and at pH 7.8, moreover, when an optical density of 0.5 OBeso is reached (measured at 650 bp), the mass is shaken for 2 hours at 40 ° C until thermal induction sensitive to the phage repressor temperature. Free phage are obtained from the liquid culture medium by precipitation with polyethylene glycol, followed by purification using a density gradient of cesium chloride. After extraction with phenol and dialysis against a buffer solution of 10, mM Tris-HCl, pH 8.0, 0.6 mg of purified VDA phage are obtained.
    In order to clone a P1 raf DNA fragment, an SCA plasmid vector pBR 322 is used, which contains marker genes for ampicillin and tetragon resistance as marker genes.
    The Escherichia coli strain, containing pBR 322, is cultured with shaking at 37 ° C in 1 L of nutrient broth until the end of the exponential growth phase. Then, after adding 150 mg / ml of chloramphenicol, shaking is continued for 15 hours at the same temperature. With

    this plasmid accumulated mainly in bacteria. After that, bacterial cells are obtained, lysing with lysozyme and non-ionic detergent. The lysate is centrifuged for 30 minutes under a load of 48,000 g in order to obtain a clear liquid. From this liquid 0, using a double centrifugation at equilibrium density gradient using cesium chloride and ethidium bromide, followed by extraction with phenol and dialysis 15 with respect to the buffer solution (10 mM Tris-HCl, pH 8.0), receive 420 µg of plasmid DNA.
    According to IO μg P1 raf DNA and vector DNA, the S1I endonuclease is treated at 37 ° C for 20–1 h in order to completely cleave the DNA molecules, and then heat to 65 ° C for 5 min.
    After that, P1 raf DNA is fractionated by electrophoresis on O, agar gel. A relative molecular weight fragment of four megadaltons was separated and after extraction with phenol and dialysis in 30 buffer solution (10 mM Tris-HCL pH 8.0) was prepared in solution.
    The solution of the P1 raf DNA fragment obtained by this method is mixed with a solution of the pBR.322 digested DNA carrier and after the addition of dATP. dithiozritrite and magnesium chloride for 24 hours at 4 ° C are exposed to phage T4 DNA ligase.
    Normal E. coli Slurry (BMTV 2744,
    40 DSM 2093), with shaking, cultured in 50 ml of nutrient broth at 37 ° C until the end of the exponential growth phase. The cells are separated and suspended in an ice bath in a 50 mM plant.
    45 thief of calcium chloride.
    The prepared suspension is mixed with a solution of the recombinant DNA, kept for 20 minutes in an ice bath, and then heated for 3 minutes to 37 C. The cells are subcultured in nutrient broth and shaken at 37 ° C for 45 minutes, as a result whereby the transformation reaction takes place completely. The cells are separated, washed and suspended again. A small portion of the cell suspension is applied to an agar-coated plate, the agar containing 35
    50
    3
    Lives per liter of 10.5-g К2НР04, 4.5 g КН, Р04, 1 g (NH4) SO4, 0.5 g sodium citrate, 0.1 g magnesium sulfate 7, 1 mg thiamine, 2 g raffinose, 25 g of ampicillin and 15 g of agar (pH 7.2); the plate is kept at 37 ° C. After being left for 2 days, numerous plates appeared on the plate 43
    1681
    . The SRI for whites is 1: 4 in the first case, 1: 3 in the second case.
    Red colonies in all cases split raffinose, i.e. they still contain the whole raf operon. White cells do not have the ability to cleave raffinose. However, they all produce the enzyme ci-galactosidase.
    lyennye colonies. All colonies are harvested, 10 as shown by the test in the free of
    purified and separated.
    Each of the colonies obtained by the above method has the ability to use raffinose as the sole carbon source and single-15 nosuses are cultivated in nutrient broo.
    temporarily resistant to ampicillin. Thus, they have different properties compared to the strain that was used as a host organism.
    Plasmid DNA was isolated from the resulting colonies in each case.
    I select a plasmid from the colonies, which, after being treated with the Eco R I or Hind III enzyme, produce a smaller second fragment than the plasmids from other colonies. Bacteria that carry this plasmid can use raffinose as the sole carbon source and produce all the operon enzymes.
    10 μg of pBT 100 DNA from BMTV 2741 (DSM 2090) is treated for 1 hour at 27 ° C with either Hind III endonuclease or Eco RI endonuclease in order to cleave the DNA molecules. It is then heated at 65 ° C for 5 minutes.
    The solution is treated in this way with plasmid DNA, treated with T4 ligase.
    Immediately thereafter, the cell components of the E. coli strain are treated with a solution of renatured DNA. A small part of the cells treated in this way was applied onto Mae Sopseu Paffincse plates (Difco Labaratories Detroit) with 25 µg / ml ampicillin. In the case of transformation with plasmid DNA, the plates are pretreated with Hind III, after aging for 24 hours at 27 ° C approximately 20 colonies are formed, and approximately 30 colonies are detected on the plates in the case of DfIA transformation, previously treated with EcoR1. The ratio of red cols.
    it is at 37 ° C before the formation of the stationary phase. Therefore, these cells have different properties compared to the host organism or cells.
    BMTV 2741 (BSM 2090) kami, which are transformed using pBT 100.
    The plasmid, which after the previous Hind III treatment of rBT 100 is obtained on the Mae Sopseu plates as white colonies, is called pBT 101, and the plasmid obtained as a result of the previous reaction with Eco RI is called pBT 102. E. coli strain with pBT 102
    30 is called the BMTV 2742 (DSM 2091).
    In tab. 1 shows the experimental results of tests of the cell free extract for the content of o6-galactosidase c
    35 o1-PMPH after cultivation at 25 ° C BMTV 2742.- The cells are incubated in 10 ml of nutrient broth in a flask with a capacity of 10% ml, after which they are shaken at 30 ° C for 15 hours. The experience was carried out by cultivating the original BTMV 2743 strain under the same conditions, but adding 0.2% raffinose to the medium.
    As from tab. 1, the extract of strain 45 Ma BNTV 2742 compared with BWV 2743 is characterized by a significantly higher content of galactosidase.
    Strain, No.
    50
    Activity of, -galactosidase, and / mg
    EMTV 2742. (DSM) 209l)
    . BMTV 2743 .55 (DSM 2092)
    ten
    0.4
     mg of dissolved protein in the raw extract.
    extract current with p-nitrophenyl-o.-galactoside {oi-PNPG) as a colored substrate, in the case when the cells are without prior addition of raffio.
    it is at 37 ° C before the formation of the stationary phase. Therefore, these cells have different properties compared to the host organism or
    BMTV 2741 (BSM 2090) kami, which are transformed using pBT 100.
    The plasmid, which after the previous Hind III treatment of pBT 100 is obtained on the Mae Sopseu plates as white colonies, is called pBT 101, and the plasmid obtained as a result of the previous reaction with Eco RI is called pBT 102. E. coli strain with pBT 102
    called the BMTV 2742 (DSM 2091).
    In tab. 1 shows the experimental results of tests of the cell free extract for the content of o6-galactosidase c
    o1-PMPH after cultivation at 25 ° C BMTV 2742.- The cells are incubated in 10 ml of nutrient broth in a flask with a capacity of 10% ml, after which they are shaken at 30 ° C for 15 hours. The control experiment is carried out by cultivating the original strain BTMV 2743 under the same conditions, but when 0.2% raffinose is added to the medium.
    As from tab. 1, the extract of the strain BNTV 2742 as compared to BWV 2743 is characterized by a significantly higher content of galactosidase.
    Strain, No.
    50
    Activity of, -galactosidase, and / mg
    EMTV 2742. (DSM) 209l)
    BMTV 2743 (DSM 2092)
    ten
    0.4
     mg of dissolved protein in the raw extract.
    When these conditions were met, a known strain of E.coli BMTV 2744 showed activity: 0.001 and / mg,
    Pieces amm E.coli D 2091 has all the properties typical of E. coli.i strains.
    Morphologists: sticks, single or double.10
    Development: aerobic or optionally anaerobic, optimally at 37 ° C.
    Other characteristics: gram-negative, non-sporulating Oakteri, chemo-orgamotroph catalase-positive, oxidase-negative.
    It contains the plasmid rBT 102, is resistant to ampicillin at a concentration of 50 µg / ml, and intracellularly produces ob-galactosidase, which does not need. presence of additional agents, but does not produce inversion. Otherwise, it does not differ from the E. coli K-12 strain and can be cultured at 37 ° C on a standard medium, most appropriately with aeration.
    权利要求:
    Claims (1)
    [1]
    1. A method of producing oi-galactosidase by cultivating microorganisms in a nutrient medium containing carbon, nitrogen and mineral salts, followed by excretion and purification of the target pro-.
    20
    25
    681
    duk that
    characterized in
    0
    0
    0
    five
    that, in order to increase the degree of purity of the enzyme by reducing the content of invertase, DNA containing the o-galactosidase gene was isolated from E. coli strain DSM 2092, digested with the endonuclease Sal I DNA, carrying the oi-galactoside gene - zy about four megapadalton in size, after the resulting fragment is stitched with the restriction enzyme Sal I with the pBR 322 vector containing the ampicillin resistance gene, in the presence of the phage T4 DNA ligase with the addition of ATP, dithioetrite and magnesium chloride, the recombinant DNA incubator obtained is added; with E. cells The coli transformed cells are cultured on a nutrient medium containing 2-10 g / l raffinose, the resulting ampicillin-resistant colonies are separated and lysed, and plasmid DNA of 6.9-12.4 megadalton is digested from the lysate, which is digested. - the endonuclease Hidn III and scrub DNA-ingiase, the resulting renaturated plasmid pBT 102 is suspended with E. coli cells, the transformants are again cultured on a nutrient medium containing 2-10 g / l raffinose and ampicillin, E. coli colonies are selected, using raffinose and get the target product ct cultivation of these clones of microorganisms ..
    2, The strain of bacteria Escherichia coli - DSM 2091 - producingi-galactosidase.
    类似技术:
    公开号 | 公开日 | 专利标题
    SU1431681A3|1988-10-15|Method of producing alpha-galactosidase and strain of escherichia coli bacteria - producer of alpha-galactosidase
    Tandeau de Marsac et al.1987|Expression of the larvicidal gene of Bacillus sphaericus 1593M in the cyanobacterium Anacystis nidulans R2
    US5608036A|1997-03-04|Enhanced secretion of polypeptides
    McGILLIVRAY et al.1986|Applied electrical fields polarize the growth of mycelial fungi
    AU594062B2|1990-03-01|Bacterial enzymes
    DD212532A5|1984-08-15|METHOD FOR STABILIZING AND SELECTION OF HOST CELLS CONTAINING RECOMBINANT DNA
    KR20000075076A|2000-12-15|A method for production of foreign protein using transformed microalgae
    Poteete et al.1980|Operator sequences of bacteriophages P22 and 21
    DE60127561T2|2007-12-13|PHAGEN-DEPENDENT SUPER PRODUCTION OF BIOLOGICALLY ACTIVE PROTEINS AND PEPTIDES
    Green et al.1969|Effect of a recA gene on cell division and capsular poly-saccharide production in a lon strain of Escherichia coli
    EP0290768A2|1988-11-17|Process for the production of glucose dehydrogenase from Bacillus megaterium
    KR100654029B1|2006-12-05|Plasmid-free clone of e. coli strain dsm 6601
    Gyohda et al.2000|Purification and characterization of the R64 shufflon-specific recombinase
    SU1443806A3|1988-12-07|Method of constructing plasmodium vector phc314 or phc312 or phc624
    KR20120096220A|2012-08-30|Enhancer element of the epha7 gene and uses thereof
    CN108368512B|2020-03-27|Preparation method of recombinant human granulocyte colony stimulating factor
    Krause et al.1984|On the Mu repressor and early DNA intermediates of transposition
    DE2930922C2|1988-04-14|
    Pospiech et al.1993|Detection of developmentally regulated genes of the myxobacterium Stigmatella aurantiaca with the transposon Tn5lacZ
    EP0214548B1|1991-12-27|Dna sequences, recombinant dna molecules and process for the preparation of the enzyme mutarotase of acinetobacter calcoaceticus
    JP2801263B2|1998-09-21|Method for isolating and subsequently purifying carbamate-hydrolase, method for producing BrCN-degraded peptide of carbamate-hydrolase, synthetic oligonucleotide, method for isolating carbamate-hydrolase-gene, and novel strain of Arthrobacter oxydans
    KR940004543B1|1994-05-25|Method of producing vector
    US5827687A|1998-10-27|Promoter and method of gene expression using the same
    DE102004035543A1|2006-02-09|Nucleic acid to be coded for signal peptide-peptidase A, to give genes/genetic products for protein production through microorganisms, has a defined nucleotide sequence
    Wight et al.1989|Stimulation of extracellular protein production in Bacillus brevis 47
    同族专利:
    公开号 | 公开日
    AU531972B2|1983-09-15|
    DE3122216A1|1982-12-23|
    US5061625A|1991-10-29|
    DK251682A|1982-12-05|
    CA1194433A|1985-10-01|
    JPS6251588B2|1987-10-30|
    EP0066857B1|1987-09-09|
    DD202735A5|1983-09-28|
    AU8382682A|1982-12-09|
    CS272753B2|1991-02-12|
    HU193266B|1987-09-28|
    DD210467A5|1984-06-13|
    EP0066857A2|1982-12-15|
    DE3277213D1|1987-10-15|
    EP0066857A3|1983-06-22|
    CS363582A2|1990-06-13|
    JPS57208985A|1982-12-22|
    AT29525T|1987-09-15|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    RU2504583C1|2012-10-03|2014-01-20|Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук |PLASMID 40Gal DETERMINING SYNTHESIS OF α-GALACTOSIDASE α-PsGal, STRAIN Ecoli Rosetta/40Gal - PRODUCER OF CHIMERIC PROTEIN CONTAINING AMINO-ACID SEQUENCE α-PsGal, AND METHOD FOR ITS PRODUCTION|US3957578A|1975-01-03|1976-05-18|Hokkaido Sugar Co., Ltd.|Method for manufacture of α-galactosidase by microorganism|NZ208612A|1983-06-24|1991-09-25|Genentech Inc|Method of producing "procaryotic carbonyl hydrolases" containing predetermined, site specific mutations|
    SU1364343A1|1984-07-13|1988-01-07|Всесоюзный научно-исследовательский институт генетики и селекции промышленных микроорганизмов|Method of producing manъs leukocytic interferon alfa-2|
    US5240838A|1984-07-27|1993-08-31|Internationale Otrool Maatschappij "Octropa" B.V.|Regulatory sequences of alcohol oxidaseand dihydroxyacetonesynthaseof Hansenula polymorpha|
    US5741672A|1984-07-27|1998-04-21|Unilever Patent Holdings B.V.|Expression and production of polypeptides using the promoters of the hansenula polymorpha MOX and DAS genes|
    FI861548A0|1986-04-11|1986-04-11|Alko Ab Oy|NYA JAESTSTAMMAR VARI MED GENTEKNISKA FOERFARANDEN INFOERTS EN -GALAKTOSIDASGEN OCH FOERFARANDEN FOER INDUSTRIELLT UTNYTTJANDE AV DYLIKA JAESTSTAMMAR.|
    CA1339101C|1986-06-03|1997-07-29|Nicolaas Overbeeke|Production of guar alpha-galactosidase and immunologically related alpha-galactosidases by host organisms transformed with recombinant dna methods|
    EP0255153B1|1986-06-03|1995-01-18|Unilever N.V.|Production of guar alpha-galactosidase by hoststransformed by recombinant DNA methods|
    EP0487159A1|1990-11-23|1992-05-27|Unilever N.V.|A food-grade vector suitable for transforming a food-grade host cell, use of said vector for transforming food-grade host cells, and use of said transformed cells in biotransformation processes|
    US6770468B1|1999-09-14|2004-08-03|Genzyme Glycobiology Research Institute, Inc.|Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway|
    US6642038B1|1999-09-14|2003-11-04|Genzyme Glycobiology Research Institute, Inc.|GlcNAc phosphotransferase of the lysosomal targeting pathway|
    US6800472B2|2001-12-21|2004-10-05|Genzyme Glycobiology Research Institute, Inc.|Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    DE19813122216|DE3122216A1|1981-06-04|1981-06-04|METHOD FOR PRODUCING A MICROORGANISM, WHICH-GALACTOSIDASE BUT DOES NOT CREATE INVERTASE, MICROORGANISM OBTAINED IN THIS OBTAIN, AND ITS USE|
    [返回顶部]